Retifanlimab with platinum-based chemotherapy for treating inoperable, locally recurrent or metastatic squamous cell anal canal cancer untreated with systemic chemotherapy ID6482
[ID6482]
In development
Reference number: GID-TA11625
Expected publication date: TBC
Documents
Documents created during the development process.
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6482